REGULATED PRESS RELEASE published on 01/03/2024 at 17:45, 10 months 17 days ago CNP Assurances strengthens its position in the insurance of the Préfon Retraite scheme CNP Assurances strengthens its position in the insurance of the Préfon Retraite scheme by making changes to its reinsurance agreements, which will have a positive impact on the scheme's prospects and the guarantees of its 400,000 members. This move aligns with CNP Assurances' strategy to strengthen its multi-partner model and develop solutions that cater to the population's concerns such as social protection and retirement preparation. CNP Assurances Préfon Retraite Reinsurance Insurance Multi-partner Model
REGULATED PRESS RELEASE published on 12/18/2023 at 18:00, 11 months 2 days ago CNP Assurances announces the sale of its interest in iSalud
REGULATED PRESS RELEASE published on 11/09/2023 at 18:00, 1 year ago S&P Global Ratings maintains the rating of CNP Assurances SA
REGULATED PRESS RELEASE published on 10/13/2023 at 08:10, 1 year 1 month ago Fitch Ratings affirms CNP Assurances SA’s insurer financial strength rating at A+
REGULATED PRESS RELEASE published on 10/04/2023 at 10:45, 1 year 1 month ago 2023 Half-Yearly Financial Report available online
Published on 11/21/2024 at 13:30, 13 minutes ago AirIQ Announces September 30, 2024 Quarterly Results Company Reports Double-Digit Growth in Recurring Revenue
Published on 11/21/2024 at 13:30, 13 minutes ago Datametrex Secures Additional P.O. Approx $250K for IT Services
Published on 11/21/2024 at 13:00, 43 minutes ago Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Published on 11/21/2024 at 13:00, 43 minutes ago Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Published on 11/21/2024 at 13:00, 43 minutes ago Toggle3D.ai Rebrands as FOTOgpt.ai to Usher in a New Age of AI-Powered Photography
Published on 11/21/2024 at 12:35, 1 hour 8 minutes ago audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 1 hour 28 minutes ago Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 06:58, 6 hours 45 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 23 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 19 hours 58 minutes ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 19 hours 58 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 5 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo